What are the contraindications for adding duloxetine (Cymbalta) to a treatment regimen for a patient with chronic low back pain and no significant medical comorbidities?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications for Adding Duloxetine

The absolute contraindications for adding duloxetine are concurrent use with MAOIs (including within 5 days of stopping duloxetine or within 14 days of stopping an MAOI), and concurrent use with linezolid or intravenous methylene blue due to the risk of serotonin syndrome. 1

Absolute Contraindications

  • MAOI use: Do not use duloxetine with any MAOI intended to treat psychiatric disorders, as this combination creates an unacceptable risk of serotonin syndrome 1
  • Timing restrictions: Wait at least 5 days after stopping duloxetine before starting an MAOI, and wait at least 14 days after stopping an MAOI before starting duloxetine 1
  • Linezolid or IV methylene blue: Do not initiate duloxetine in patients currently receiving these medications due to their MAOI-like properties 1

Relative Contraindications and Cautions

  • Uncontrolled narrow-angle glaucoma: Duloxetine may precipitate angle-closure attacks in susceptible patients 1
  • Severe hepatic impairment: Duloxetine undergoes extensive hepatic metabolism and should be avoided in patients with cirrhosis or significant liver disease 1
  • Severe renal impairment (CrCl <30 mL/min): Duloxetine is not recommended in patients with end-stage renal disease or severe renal dysfunction 1
  • Concurrent use of other serotonergic drugs: Exercise caution when combining duloxetine with SSRIs, SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, or St. John's Wort due to additive serotonin syndrome risk 1

Clinical Considerations for Chronic Low Back Pain

  • Evidence supports use: Duloxetine 60 mg daily demonstrates small but significant improvements in pain intensity (0.60-0.79 points on a 0-10 scale) and function in chronic low back pain patients 2
  • Discontinuation risk: Approximately 13.9-15.2% of patients discontinue duloxetine due to adverse events, compared to 5.4-8.5% with placebo 3, 4, 5
  • Common adverse effects: Nausea, dry mouth, fatigue, diarrhea, hyperhidrosis, dizziness, and constipation are the most frequently reported side effects 4
  • Elderly patients: Use with particular caution in older adults due to increased fall risk from dizziness and sedation 6

Medication Interactions to Screen

  • NSAIDs: While duloxetine can be combined with NSAIDs for chronic low back pain, monitor for increased bleeding risk when used together 2, 6
  • Anticoagulants/antiplatelets: Duloxetine may increase bleeding risk when combined with warfarin, aspirin, or other anticoagulants 1
  • Alcohol: Advise patients to avoid alcohol due to increased hepatotoxicity risk 1

Screening Before Initiation

  • Check current medication list for MAOIs, linezolid, or other serotonergic agents 1
  • Assess liver function with baseline transaminases if liver disease is suspected 1
  • Evaluate renal function with serum creatinine and estimated GFR 1
  • Screen for history of mania or bipolar disorder, as duloxetine may precipitate manic episodes 1
  • Assess for suicidal ideation, particularly in younger patients, as antidepressants carry a black box warning for increased suicidality in patients under age 24 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.